Bioreactor Systems for Tissue Engineering
278,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Gebundenes Buch

The editors of this special volume would first like to thank all authors for their excellent contributions. We would also like to thank Prof. Dr. Thomas Scheper, Dr. Marion Hertel and Ulrike Kreusel for providing the opportunity to compose this volume and Springer for organizational and technical support. Tissue engineering represents one of the major emerging fields in modern b- technology; it combines different subjects ranging from biological and material sciences to engineering and clinical disciplines. The aim of tissue engineering is the development of therapeutic approaches to…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
The editors of this special volume would first like to thank all authors for their excellent contributions. We would also like to thank Prof. Dr. Thomas Scheper, Dr. Marion Hertel and Ulrike Kreusel for providing the opportunity to compose this volume and Springer for organizational and technical support. Tissue engineering represents one of the major emerging fields in modern b- technology; it combines different subjects ranging from biological and material sciences to engineering and clinical disciplines. The aim of tissue engineering is the development of therapeutic approaches to substitute diseased organs or tissues or improve their function. Therefore, three dimensional biocompatible materials are seeded with cells and cultivated in suitable systems to generate functional tissues. Many different aspects play a role in the formation of 3D tissue structures. In the first place the source of the used cells is of the utmost importance. To prevent tissue rejection or immune response, preferentially autologous cells are now used. In particular, stem cells from different sources are gaining exceptional importance as they can be differentiated into different tissues by using special media and supplements. In the field of biomaterials, numerous scaffold materials already exist but new composites are also being developed based on polymeric, natural or xenogenic sources. Moreover, a very important issue in tissue en- neering is the formation of tissues under well defined, controlled and reprod- ible conditions. Therefore, a substantial number of new bioreactors have been developed.
Autorenporträt
Priv.-Doz. Dr.-Ing. Ralf Pörtner, geb. 1958 in Melle. 1978-1984 Studium der Chemietechnik in Dortmund. 1989 Promotion Uni Dortmund, Mechanische Verfahrenstechnik. 1989-1990 Post-Doc Uni Tsukuba, Japan. Seit 1990 Oberingenieur und Leiter Arbeitsgruppe Zellkulturtechnik und Tissue Engineering, TU Hamburg-Harburg, Institut für Bioprozess- und Biosystemtechnik. 2002-2007 Lehrbeauftragter HAW Hamburg. Seit 2008 Lehrbeauftragter an der FH Gießen-Friedberg. 1997 Habilitation und Ernennung zum Privatdozenten. Mitkoordinator des Forschungsschwerpunktes Regeneration, Implantate und Medizintechnik der TU Hamburg-Harburg und Sprecher der Forschungsgruppe Tissue Engineering. Studiengangkoordinator Bioverfahrenstechnik. Etwa 60 referierte Arbeiten sowie über 120 Tagungsbeiträge zu den Themen Zellkulturtechnik, Steuerung von Bioreaktoren, Tissue Engineering.